Clonal expansion and rapid characterization of <i>Klebsiella pneumoniae</i> ST1788, an otherwise uncommon strain spreading in Wales, UK.

Authors:
Mentasti M; David S; Turton J; Morgan M; Turner L and 10 more

Journal:
Microb Genom

Publication Year: 2023

DOI:
10.1099/mgen.0.001104

PMCID:
PMC10569728

PMID:
37668148

Journal Information

Full Title: Microb Genom

Abbreviation: Microb Genom

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Microbiology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"esbl kl2 klebsiella pneumoniae multidrug resistance pcr st1788 yersiniabactin openaccessembargo 0 genome data generated and/or analysed in this work are available in the european nucleotide archive (ena) under project number erp135832 or prjeb48990.; short read data were made available on the european nucleotide archive (ena) under project accession erp135832; short read data for the 43 st1788 strains previously sequenced are also available on the ena under project accession prjeb48990.; in this clade also there is evidence of wider geographical spread of strains as it includes three isolates from three patients admitted to hospital h or hospital k located in south east wales with no admission history to hospitals a or i finally interspersed within this clade are 11 strains isolated from eight patients attending general practices located both in south east and south west wales; four of these strains were from four patients with no history of admission to hospital a or hospital i during this study a new bla shv variant and a new bla ctx-m variant were identified; these variants were submitted to genbank and later designated as bla shv-232 (accession or224963) and bla ctx-m-266 (accession or224962)."

Code Sharing
Evidence found in paper:

"Conflicts of interest The authors declare no conflicts of interest."

Evidence found in paper:

"Funding information S.D. is supported by funding from the Centre for Genomic Pathogen Surveillance and the Bill and Melinda Gates Foundation (investment no. INV-025280). Illumina sequencing was funded as part of the Antimicrobial Resistance and Genomic Typing Project (ARGENT) by the Welsh Assembly Government."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025